Skip to content

CHECK OUT OUR FEATURED SPEAKERS FOR THIS YEAR’S EVENT

This event is invite only

THANK YOU FOR JOINING US AT AVICANNA’S 5TH MEDICAL SYMPOSIUM

We were honoured to host our fifth annual event, where healthcare professionals and industry leaders came together to explore the evolving role of medical cannabis in clinical care. Each session offers the latest research, real-world insights, and patient-centered strategies in the field, covering the topics of:

  1. Medical Cannabis Research and Innovations
  2. Challenges Faced by Patients and Breaking Barriers for Access
  3. Pain and Harm Reduction
  4. Bridging Science and Practice: The Future of Medical Cannabis in Clinical Care

THANK YOU TO EVERYONE WHO JOINED US AT THIS YEAR’S EVENT

We had the pleasure of hosting our 5th Annual Medical Symposium on June 6, 2025, where attendees had the opportunity to join medical professionals and industry leaders presenting the latest advancements in medical cannabis.

The videos below showcase all the compelling presentations and panel discussions on the various of topics that were presented throughout the four sessions.
1. Medical Cannabis Research and Innovations
2. Challenges Faced by Patients & Breaking Barriers for Access
3. Pain & Harm Reduction
4. Bridging Science and Practice: The Future of Medical Cannabis in Clinical Care

Opening Remarks

Dr. Karolina Urban

Opening Remarks

Examining the Therapeutic Potential of Cannabigerol

Dr. Carrie Cuttler, PhD, Washington State University

Getting by Without the High: Examining the Therapeutic Potential of Cannabigerol

A Role for Cannabinoids in the Management of Arthritis

Dr. Jason McDougall, PhD, Dalhousie University

A Role for Cannabinoids in the Management of Arthritis

Panel 1: Beyond the Lab

Dr. Carrie Cuttler, Dr. Jason McDougall, Dr. Kelly Dunn, Dr. Karolina Urban

Breakthroughs Transforming the Medical Cannabis Space

Tales From the Front Lines

Dr. Carlo DeAngelis, PharmD, Sunnybrook Health Sciences Centre, University of Toronto

Unique Uses of Medical Cannabis – Patient Cases

Building Better Drugs Education

Daniel Bear, PhD, Humber College, Centre for Social Innovation

Building Better Drugs Education for People Who Know a Lot About (Certain) Drugs – Considerations for Medical Cannabis

Panel 2: Bridging the Gap

People with Lived Experience, with Dr. Azhar Rana

Exploring the Patient Perspective and Breaking Barriers to Access

Cannabis and Problematic Substance Use

Dr. Zachary Walsh, PhD, RPsych, BC Centre on Substance Use, University of British Columbia

New Findings on Substitution and Harm Reduction From High-Risk Populations

Opioid-Cannabinoid Interactions

Dr. Kelly Dunn, PhD, MBA, John Hopkins School of Medicine, University of Maryland

Human Laboratory Evidence of Opioid-Cannabinoid Interactions and the Role of Opioids

Short Poster Presentations

Short Poster Presentations

Cannabis Use Among Older Adults

Dr. Jennifer Baumbusch, RN, PhD, UBC School of Nursing

Cannabis Use among Older Adults: Current Research and Implications for Clinical Practice

Cannabinoids in Psychiatry

Martin A. Katzman BSc, MD, FRCPC, START Clinic for the Mood and Anxiety Disorders, Northern Ontario School of Medicine & Psychology, Lakehead University

Understanding Where It Is In Your Practice and Why

Cannabis-Based Therapies for Epilepsy

Dr. Evan Lewis, MD, FRCPC, North Toronto Neurology, University Of Toronto, Pediatrics

What’s New & What’s Next

Panel 3: Clinical Benefit of Medical Cannabis

Dr. Lewis, Dr. Zachary Walsh, Dr. Martin A. Katzman, Dr. Azhar Rana

Demystifying Opportunities in Clinical Practice

Closing Remarks

Aras Azadian

Closing Remarks

If you are a Healthcare Provider and would like more information, contact us at info@avicanna.com.